Device Trial Radar · NCT06429748
Symptom Evaluation Following Repetitive Transcranial Magnetic Stimulation
Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
20
Actual
Start
May 15, 2024
Primary completion
Apr 29, 2025
Study completion Dec 30, 2027
Sponsor
- Lead sponsor
- NeuroneticsAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 28, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 70 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective study to evaluate symptoms following repetitive transcranial Magnetic stimulation.
Conditions
- Neurologic Symptoms
Interventions
rTMSDevice
repetitive Transcranial Magnetic Stimultion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Changes in multiple symptoms after rTMS treatment.Time frame: 4 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Charlotte Skin and Laser
Charlotte, North Carolina
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.